Exercise of high intensity ameliorates hepatic inflammation and the progression of NASH

被引:51
|
作者
Fredrickson, Gavin [1 ]
Barrow, Fanta [1 ]
Dietsche, Katrina [1 ]
Parthiban, Preethy [1 ]
Khan, Saad [2 ,3 ]
Robert, Sacha [1 ]
Demirchian, Maya [1 ]
Rhoades, Hailey [1 ]
Wang, Haiguang [1 ]
Adeyi, Oyedele [4 ]
Revelo, Xavier S. [1 ,5 ]
机构
[1] Univ Minnesota, Dept Integrat Biol & Physiol, Minneapolis, MN 55455 USA
[2] Univ Toronto, Dept Immunol, Toronto, ON M5S 1A8, Canada
[3] Univ Hlth Network, Toronto Gen Hosp, Res Inst, Div Cellular & Mol Biol, Toronto, ON M5G 1L7, Canada
[4] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA
[5] Univ Minnesota, Ctr Immunol, Minneapolis, MN 55455 USA
来源
MOLECULAR METABOLISM | 2021年 / 53卷
关键词
NASH; NAFLD; Exercise; HIIT; Inflammation; FATTY LIVER-DISEASE; DIET-INDUCED-OBESITY; NONALCOHOLIC STEATOHEPATITIS; MACROPHAGE INFILTRATION; INSULIN-RESISTANCE; INTERVAL EXERCISE; RECEPTOR; INCREASES; MODERATE; FIBROSIS;
D O I
10.1016/j.molmet.2021.101270
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Non-alcoholic fatty liver disease (NAFLD) covers a wide spectrum of liver pathology ranging from simple fatty liver to non-alcoholic steatohepatitis (NASH). Notably, immune cell-driven inflammation is a key mechanism in the transition from fatty liver to the more serious NASH. Although exercise training is effective in ameliorating obesity-related diseases, the underlying mechanisms of the beneficial effects of exercise remain unclear. It is unknown whether there is an optimal modality and intensity of exercise to treat NAFLD. The objective of this study was to determine whether high-intensity interval training (HIIT) or moderate-intensity continuous training (MIT) is more effective at ameliorating the progression of NASH. Methods: Wild-type mice were fed a high-fat, high-carbohydrate (HFHC) diet for 6 weeks and left sedentary (SED) or assigned to either an MIT or HIIT regimen using treadmill running for an additional 16 weeks. MIT and HIIT groups were pair-fed to ensure that energy intake was similar between the exercise cohorts. To determine changes in whole-body metabolism, we performed insulin and glucose tolerance tests, indirect calorimetry, and magnetic resonance imaging. NASH progression was determined by triglyceride accumulation, expression of inflammatory genes, and histological assessment of fibrosis. Immune cell populations in the liver were characterized by cytometry by time-of -flight mass spectrometry, and progenitor populations within the bone marrow were assessed by flow cytometry. Finally, we analyzed the transcriptional profile of the liver by bulk RNA sequencing. Results: Compared with SED mice, both HIIT and MIT suppressed weight gain, improved whole-body metabolic parameters, and ameliorated the progression of NASH by reducing hepatic triglyceride levels, inflammation, and fibrosis. However, HIIT was superior to MIT at reducing adiposity, improving whole-body glucose tolerance, and ameliorating liver steatosis, inflammation, and fibrosis, without any changes in body weight. Improved NASH progression in HIIT mice was accompanied by a substantial decrease in the frequency of pro-inflammatory infiltrating, monocyte-derived macrophages in the liver and reduced myeloid progenitor populations in the bone marrow. Notably, an acute bout of MIT or HIIT exercise had no effect on the intrahepatic and splenic immune cell populations. In addition, bulk mRNA sequencing of the entire liver tissue showed a pattern of gene expression confirming that HIIT was more effective than MIT in improving liver inflammation and lipid biosynthesis. Conclusions: Our data suggest that exercise lessens hepatic inflammation during NASH by reducing the accumulation of hepatic monocyte-derived inflammatory macrophages and bone marrow precursor cells. Our findings also indicate that HIIT is superior to MIT in ameliorating the disease in a dietary mouse model of NASH. (c) 2021 The Author(s). Published by Elsevier GmbH. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
引用
收藏
页数:13
相关论文
共 50 条
  • [1] Amelioration of hepatic inflammation in a mouse model of NASH using a dithiocarbamate derivative
    Schwartz, Jason J.
    Emerson, Lyska
    Hillas, Elaine
    Phan, Ann
    Thiesset, Heather
    Firpo, Matthew
    Sorensen, Jeffrey
    Kennedy, Thomas
    Rinella, Mary
    HEPATOLOGY INTERNATIONAL, 2013, 7 (02) : 600 - 609
  • [2] Rosavin Ameliorates Hepatic Inflammation and Fibrosis in the NASH Rat Model via Targeting Hepatic Cell Death
    Albadawy, Reda
    Hasanin, Amany Helmy
    Agwa, Sara H. A.
    Hamady, Shaimaa
    Aboul-Ela, Yasmin M.
    Raafat, Mona Hussien
    Kamar, Samaa Samir
    Othman, Mohamed
    Yahia, Yahia A.
    Matboli, Marwa
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (17)
  • [3] Inhibiting Monoacylglycerol Acyltransferase 1 Ameliorates Hepatic Metabolic Abnormalities but Not Inflammation and Injury in Mice
    Soufi, Nisreen
    Hall, Angela M.
    Chen, Zhouji
    Yoshino, Jun
    Collier, Sara L.
    Mathews, James C.
    Brunt, Elizabeth M.
    Albert, Carolyn J.
    Graham, Mark J.
    Ford, David A.
    Finck, Brian N.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2014, 289 (43) : 30177 - 30188
  • [4] Liver cyclophilin D deficiency inhibits the progression of early NASH by ameliorating steatosis and inflammation
    Li, Xiaoling
    Yang, Mengjiao
    Sun, Hang
    ul Ferdous, Md Reyad
    Gao, Ling
    Zhao, Jiajun
    Song, Yongfeng
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2022, 594 : 168 - 176
  • [5] Curcumin ameliorates liver damage and progression of NASH in NASH-HCC mouse model possibly by modulating HMGB1-NF-κB translocation
    Afrin, Rejina
    Arumugam, Somasundaram
    Rahman, Azizur
    Wahed, Mir Imam Ibne
    Karuppagounder, Vengadeshprabhu
    Harima, Meilei
    Suzuki, Hiroshi
    Miyashita, Shizuka
    Suzuki, Kenji
    Yoneyama, Hiroyuki
    Ueno, Kazuyuki
    Watanabe, Kenichi
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2017, 44 : 174 - 182
  • [6] Lipid Related Genes Altered in NASH Connect Inflammation in Liver Pathogenesis Progression to HCC: A Canonical Pathway
    Desterke, Christophe
    Chiappini, Franck
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (22)
  • [7] Annexin A5 regulates hepatic macrophage polarization via directly targeting PKM2 and ameliorates NASH
    Xu, Fang
    Guo, Mengmeng
    Huang, Wei
    Feng, Lili
    Zhu, Jiazhen
    Luo, Kangkang
    Gao, Jian
    Zheng, Bingfeng
    Kong, Ling-Dong
    Pang, Tao
    Wu, Xudong
    Xu, Qiang
    REDOX BIOLOGY, 2020, 36
  • [8] Dietary D-Allose Ameliorates Hepatic Inflammation in Mice with Non-alcoholic Steatohepatitis
    Yamamoto, Ryoko
    Iida, Ayaka
    Tankawa, Ken
    Shiratsuchi, Hideki
    Tokuda, Masaaki
    Matsui, Toshiro
    Nakamura, Tsuyoshi
    FOOD SCIENCE AND TECHNOLOGY RESEARCH, 2017, 23 (02) : 319 - 327
  • [9] Citrus reticulata Blanco peel extract ameliorates hepatic steatosis, oxidative stress and inflammation in HF and MCD diet-induced NASH C57BL/6 J mice
    Ke, Zunli
    Zhao, Yuanyuan
    Tan, Si
    Chen, Hui
    Li, Yin
    Zhou, Zhiqin
    Huang, Cheng
    JOURNAL OF NUTRITIONAL BIOCHEMISTRY, 2020, 83
  • [10] Hepatic Klf10-Fh1 axis promotes exercise-mediated amelioration of NASH in mice
    Luo, Hong-Yang
    Mu, Wang-Jing
    Chen, Min
    Zhu, Jie-Ying
    Li, Yang
    Li, Shan
    Yan, Lin-Jing
    Li, Ruo-Ying
    Yin, Meng-Ting
    Li, Xin
    Guo, Liang
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2024, 155